Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Food and Drug Administration (FDA) approval of oforglipron as a diabetes treatment as soon as possible. The company is already pursuing approval of orforglipron for obesity, and expects a decision from the FDA this spring
The Precision Peptide Genetic Test ($298) analyzes variants in genes affecting GLP-1 signaling, appetite regulation, and neurological response
Chen, Shihong et al., 2014
3-Month Protocol: $635 $212/mo save $115 6-Month Protocol: $1,200 $200/mo save $300 BPC-157 vs Alternative Treatment Costs Costs are approximate national averages
US$ 20.43
US$ 23.02
US$ 26.40
US$ 26.87
